AU Patent

AU2022282440A1 — Process for the preparation of benzoxazepin oxazolidinone compounds

Assigned to Genentech Inc · Expires 2023-11-16 · 3y expired

What this patent protects

Methods of making benzoxazepin oxazolidinone compounds as well as synthetic intermediates are described, including compound (10-2) and compound 18.

USPTO Abstract

Methods of making benzoxazepin oxazolidinone compounds as well as synthetic intermediates are described, including compound (10-2) and compound 18.

Drugs covered by this patent

Patent Metadata

Patent number
AU2022282440A1
Jurisdiction
AU
Classification
—
Expires
2023-11-16
Drug substance claim
No
Drug product claim
No
Assignee
Genentech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.